Mutation analysis of the MSMB gene in familial prostate cancer

被引：0

作者：

Z Kote-Jarai

D Leongamornlert

M Tymrakiewicz

H Field

M Guy

A A Al Olama

J Morrison

L O'Brien

R Wilkinson

A Hall

E Sawyer

K Muir

F Hamdy

J Donovan

D Neal

D Easton

R Eeles

机构：

[1] Translational Cancer Genetics Team,Department of Oncology. University of Cambridge

[2] The Institute of Cancer Research,Nuffield Department of Surgery

[3] Strangeways Laboratory,Department of Social Medicine

[4] CR-UK Genetic Epidemiology Unit,Departments of Oncology and Surgery

[5] University of Cambridge,undefined

[6] Strangeways Laboratory,undefined

[7] University of Nottingham Medical School,undefined

[8] Queens Medical Centre,undefined

[9] University of Oxford,undefined

[10] University of Bristol,undefined

[11] Surgical Oncology (Uro-Oncology: S4),undefined

[12] University of Cambridge,undefined

[13] Box 279,undefined

[14] Addenbrooke's Hospital,undefined

[15] Cancer Research UK Cambridge Research Institute & Li Ka Shing Centre,undefined

[16] The Royal Marsden NHS Foundation Trust,undefined

来源：

British Journal of Cancer | 2010年 / 102卷

关键词：

prostate cancer; SNP; gene expression;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：414 / 418

页数：4

共 50 条

[41] Gene Expression Network Analysis of Precursor Lesions in Familial Pancreatic Cancer
Tan, Ming
Schaffalitzky de Muckadell, Ove B.
Joergensen, Maiken Thyregod
JOURNAL OF PANCREATIC CANCER, 2020, 6 (01) : 73 - 84
[42] Regulators of gene expression as biomarkers for prostate cancer
Willard, Stacey S.
Koochekpour, Shahriar
AMERICAN JOURNAL OF CANCER RESEARCH, 2012, 2 (06): : 620 - 657
[43] Prostate cancer screening in men with familial predisposition
Paiss, T
Gschwend, JE
Maier, C
Eisele, M
Vogel, W
Hautmann, RE
Herkommer, K
UROLOGE A, 2002, 41 (06): : 596 - 601
[44] Gene expression analysis in prostate cancer: The importance of the endogenous control
Vajda, Alice
Marignol, Laure
Barrett, Ciara
Madden, Stephen F.
Lynch, Thomas H.
Hollywood, Donal
Perry, Antoinette S.
PROSTATE, 2013, 73 (04) : 382 - 390
[45] Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
Caterina Peraldo-Neia
Giorgia Migliardi
Maurizia Mello-Grand
Filippo Montemurro
Raffaella Segir
Ymera Pignochino
Giuliana Cavalloni
Bruno Torchio
Luciano Mosso
Giovanna Chiorino
Massimo Aglietta
BMC Cancer, 11
[46] Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis
Sun, Jian
Li, Shugen
Wang, Fei
Fan, Caibin
Wang, Jianqing
BMC MEDICAL GENETICS, 2019, 20 (01)
[47] Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer
Bachmann, N
Hoegel, J
Haeusler, J
Kuefer, R
Herkommer, K
Paiss, T
Vogel, W
Maier, C
PROSTATE, 2005, 65 (03) : 252 - 259
[48] Gene BRCA1/2 mutation in prostate cancer patients: clinical administration aspects
Koposov, P. V.
ONKOUROLOGIYA, 2016, 12 (02): : 80 - 83
[49] Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study
Zheng, SQL
Mychaleckyj, JC
Hawkins, GA
Isaacs, SD
Wiley, KE
Turner, A
Chang, BL
von Kap-Herr, C
Carpten, JD
Pettenati, M
Bleecker, ER
Walsh, PC
Trent, JM
Meyers, DA
Isaacs, WB
Xu, JF
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 528 (1-2) : 45 - 53
[50] Radiotherapy-Related Gene Signature in Prostate Cancer
Fortis, Sotirios P.
Goulielmaki, Maria
Aubert, Nicolas
Batsaki, Panagiota
Ouzounis, Sotirios
Cavouras, Dionisis
Marodon, Gilles
Stokidis, Savvas
Gritzapis, Angelos D.
Baxevanis, Constantin N.
CANCERS, 2022, 14 (20)

← 1 2 3 4 5 →